Project Grant HT94252410803
Award Date
9/1/24
Completion Date
8/31/27
Dollars Obligated
$567K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
The University of Texas MD Anderson Cancer Center, a component of the University of Texas System, received a $486,000 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The 3-year grant, with a start date of September 30, 2023, supports research targeting the PRMT5 protein in melanoma with MTAP gene loss. The funding will enable preclinical studies, including evaluating novel treatments, to advance the understanding and...
The University of Texas M.D. Anderson Cancer Center was awarded a $1,882,607 Project Grant from the Department of the Army Medical Command's Military Medical Research and Development (CFDA 12.420) program on March 15, 2025. The grant supports advanced biomedical research to transform healthcare for military service members and the broader public, with a focus on leveraging prostate cancer's unique lipid metabolism to induce therapeutic ferroptosis. The research aims to advance disease...
The University of Texas MD Anderson Cancer Center received a $647,990 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This three-year grant, effective June 1, 2024, supports research to investigate cell plasticity and epigenetic reprogramming mechanisms underlying the transition of well-differentiated to de-differentiated liposarcoma. The funding will enable basic research, translational studies, and potentially future...
The University of Texas MD Anderson Cancer Center received a $648,000.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to develop CAR T-cell therapy targeting CD94 in T/NK cell malignancies. The award period runs from September 1, 2023 to August 31, 2025. MD Anderson is a comprehensive cancer treatment and research center that has extensive experience conducting federally funded biomedical research, including...
The U.S. Defense Health Agency has awarded a $7,001,734 Project Grant to The University of Texas MD Anderson Cancer Center to advance the understanding of metastatic breast cancer through the development of a comprehensive research platform. The grant, which runs from August 15, 2024 to August 14, 2028, is funded under the Military Medical Research and Development (CFDA 12.420) program. The project aims to drive innovative cancer research and explore new approaches to prevention, diagnosis,...
The University of Texas MD Anderson Cancer Center was awarded a $1,214,999 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research to identify collateral lethal targets in prostate cancer from September 1, 2021 through August 31, 2024. The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative...
The University of Texas MD Anderson Cancer Center received a $647,998 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund research to develop image-guided, bidirectional EphB4 agonist-based therapy for ovarian cancer over a 4-year period from September 1, 2023 to August 31, 2027. MD Anderson, a comprehensive cancer treatment and research center, has extensive experience conducting basic,...
The University of Texas MD Anderson Cancer Center will receive $729,000 through a Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from August 2021 through August 2025 to translate novel discoveries in gastric adenocarcinoma biology into therapeutic advances. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to...
The University of Texas M.D. Anderson Cancer Center was awarded a $449,995.00 Project Grant from the Department of the Army's Military Medical Research and Development (CFDA 12.420) program, effective May 1, 2025 through April 30, 2029. The grant supports advanced biomedical research to investigate circulating immune complexes as biomarkers for the early detection and monitoring of ovarian cancer. This translational research project aims to transform healthcare for military service members and...
This $1,619,723 federal Project Grant award from the Department of Defense's Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides funding to The University of Texas MD Anderson Cancer Center to conduct research targeting novel mediators of breast cancer brain metastasis. The award period runs from April 1, 2024 to March 31, 2027, with the goal of developing new treatments, improving patient care, and advancing scientific understanding in this...